Antisclerotic effect of Trekrezan and its possible mechanisms.
Voronkov
M G
MG
Favorskii Institute of Chemistry, Siberian Branch, Russian Academy of Sciences, ul. Favorskogo 1, Irkutsk 664033, Russia.
Nurbekov
M K
MK
Bobkova
S N
SN
Karaulova
L K
LK
Susova
M I
MI
Rasulov
M M
MM
D000085:Acetates / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000473:pathology; D001013:Aorta, Thoracic / Q000473:pathology; D050197:Atherosclerosis / Q000188:drug therapy* / Q000503:physiopathology; D001835:Body Weight; D002784:Cholesterol / Q000378:metabolism; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D004983:Ethanolamines / Q000494:pharmacology*; D008055:Lipids / Q000737:chemistry; D008077:Lipoproteins, LDL / Q000737:chemistry; D008099:Liver / Q000187:drug effects; D011817:Rabbits; D013696:Temperature; D013997:Time Factors; D014280:Triglycerides / Q000378:metabolism
D000085:Acetates; D004338:Drug Combinations; D004983:Ethanolamines; D008055:Lipids; D008077:Lipoproteins, LDL; D014280:Triglycerides; C047413:crezacin; D002784:Cholesterol